glp 1 covered by blue cross blue shield Can employers and payers afford to cover GLP-1 drugs? Blue Cross Blue Shield of

Laboratory studies highlight its potential in areas such as wound healing, inflammation reduction, and tissue regeneration

Early use of innovative therapies and growing attention to obesity management are increasing demand

Shaobo Ding, [email protected] These authors have contributed equally to this work This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, and Rosenberg IH (1996)